Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bal-Price

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 1, 2015
Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro modelsLuise Schultz, Marie-Gabrielle Zurich, Maxime Culot, et al.
Environment International|January 5, 2021
Towards a systematic use of effect biomarkers in population and occupational biomonitoringMaryam Zare Jeddi, Nancy B Hopf, Susana Viegas, et al.
ALTEX|July 23, 2019
Corrigendum to Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
ALTEX|February 28, 2018
Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
Frontiers in Toxicology|March 25, 2024
Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gapsThomas Jaylet, Thibaut Coustillet, Nicola M Smith, et al.
ALTEX|August 25, 2016
Good Cell Culture Practice for stem cells and stem-cell-derived modelsDavid Pamies, Anna Bal-Price, Anton Simeonov, et al.
Toxicology and Applied Pharmacology|February 16, 2018
Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposesEllen Fritsche, Philippe Grandjean, Kevin M Crofton, et al.
ALTEX|January 18, 2025
Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testingEike Cöllen, Kristina Bartmann, Jonathan Blum, et al.
Archives of Toxicology|January 26, 2015
International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposesAnna Bal-Price, Kevin M Crofton, Marcel Leist, et al.
Environment International|April 21, 2026
Using effect biomarker thresholds in regulatory risk assessment: an OECD-based framework for assessing cumulative exposures to chemical mixturesAntonio F Hernández, Maryam Zare Jeddi, Martin F Wilks, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Toxicology in Vitro : an International Journal Published in Association with BIBRA|June 1, 2015
Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro modelsLuise Schultz, Marie-Gabrielle Zurich, Maxime Culot, et al.
Environment International|January 5, 2021
Towards a systematic use of effect biomarkers in population and occupational biomonitoringMaryam Zare Jeddi, Nancy B Hopf, Susana Viegas, et al.
ALTEX|July 23, 2019
Corrigendum to Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
ALTEX|February 28, 2018
Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
Frontiers in Toxicology|March 25, 2024
Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gapsThomas Jaylet, Thibaut Coustillet, Nicola M Smith, et al.
ALTEX|August 25, 2016
Good Cell Culture Practice for stem cells and stem-cell-derived modelsDavid Pamies, Anna Bal-Price, Anton Simeonov, et al.
Toxicology and Applied Pharmacology|February 16, 2018
Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposesEllen Fritsche, Philippe Grandjean, Kevin M Crofton, et al.
ALTEX|January 18, 2025
Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testingEike Cöllen, Kristina Bartmann, Jonathan Blum, et al.
Archives of Toxicology|January 26, 2015
International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposesAnna Bal-Price, Kevin M Crofton, Marcel Leist, et al.
Environment International|April 21, 2026
Using effect biomarker thresholds in regulatory risk assessment: an OECD-based framework for assessing cumulative exposures to chemical mixturesAntonio F Hernández, Maryam Zare Jeddi, Martin F Wilks, et al.
Pageof 8